Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Virtual environment education decreases anxiety before prostate cancer treatment

Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.

25 Mar 2017

Researchers study risk of thrombosis and bleeding in urological surgery

The international CLUE Working Group studied the risk of thrombosis and severe haemorrhage after urological cancer operations and other forms of urological surgery.

25 Mar 2017

Random DNA copying ‘mistakes’ account for most cancer mutations, study finds

Johns Hopkins Kimmel Cancer Center scientists report data from a new study providing evidence that random, unpredictable DNA copying "mistakes" account for nearly two-thirds of the mutations that cause cancer.

24 Mar 2017

Research suggests novel strategy to target genetic anomaly in prostate cancers

New research suggests a novel strategy to target a genetic anomaly that occurs in half of all prostate cancers.

24 Mar 2017

New technology may provide non-invasive approach to diagnose and monitor prostate cancer

Technology being developed at Washington State University provides a non-invasive approach for diagnosing prostate cancer and tracking the disease's progression.

22 Mar 2017

Vanderbilt study compares side effects, outcomes of prostate cancer treatments with active surveillance

Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association

21 Mar 2017

Study sheds light on cellular mechanisms that enable prostate cancer cells to form secondary tumours

New King's College London research sheds light on the cellular mechanisms which enable cancer cells to escape the prostate and spread to other parts of the body.

20 Mar 2017

Researchers discover new genes that help prevent prostate and other cancers

New genes which help prevent prostate, skin and breast cancer development in mice have been discovered by researchers at the Wellcome Trust Sanger Institute and their collaborators.

20 Mar 2017

Compressed course of radiation treatment benefits men with localized prostate cancer, study shows

An Ontario-led international clinical trial with 1,206 men with localized prostate cancer shows that compressing radiation treatments into four weeks from eight delivers similar outcomes.

16 Mar 2017

Study uncovers genetic link to aggressive form of prostate cancer

An international study published in the Journal of the National Cancer Institute has identified a genetic connection to the aggressive form of prostate cancer.

16 Mar 2017

Dietary anti-cancer compound from broccoli may work by influence on long non-coding RNAs

Researchers have discovered one of the reasons why broccoli may be good for your health.

16 Mar 2017

Endostatin can decrease proliferation of castration-resistant prostate cancer cells

Failure of hormone deprivation therapy, which is used to slow prostate cancer in patients, leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatment options.

10 Mar 2017

Thyroid cancer patients opting for non-intervention face challenging path, study reveals

Patients who choose not to intervene after a diagnosis of thyroid cancer face a challenging path--one that is often defined by a sense of isolation and anxiety, according to a first-of-its-kind study by researchers from The Dartmouth Institute for Health Policy and Clinical Practice and the Veteran's Administration in White River Junction, Vermont.

10 Mar 2017

Combination therapy that targets immune-busting cells effective in treating advanced prostate cancer

Advanced prostate cancer resistant to castration therapy appears to respond well to a combination of immune checkpoint blockades and treatments that target certain immune-busting cells commonly associated with poor patient prognosis and therapy resistance.

10 Mar 2017

TSRI researchers develop new drug candidates to target prostate and triple negative breast cancers

Scientists on the Florida campus of The Scripps Research Institute (TSRI) have designed two new drug candidates to target prostate and triple negative breast cancers.

9 Mar 2017

Fraunhofer researchers develop method that enables focused ultrasound to treat liver tumors

Focused ultrasound can effectively destroy tumor cells. Until now, this method has only been used for organs such as the prostate and uterus.

9 Mar 2017

Drug could activate innate anti-tumor immunity to eradicate aggressive prostate cancer in mice

Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete factors that entice neutrophils - the first-responders of the immune system - to infiltrate the tumor, where they triggered an immune response that led to tumor clearance.

9 Mar 2017

Study offers new insights into biological causes of premature baldness in men

Short men may have an increased risk of becoming bald prematurely. An international genetic study under the leadership of the University of Bonn at least points in this direction.

8 Mar 2017

Michigan Medicine opens first clinic in the United States that focuses on prostate cancer risk

It's well known that women with certain hereditary genetic mutations, particularly BRCA1 and BRCA2, have an increased risk of breast cancer. But in recent years, researchers have discovered a link between some of those same genetic mutations - along with a handful of others - and aggressive prostate cancer.

3 Mar 2017

Rheumatoid arthritis drug blocks metabolic pathway, reduces breast cancer tumors in mice

Mount Sinai researchers have discovered that a rheumatoid arthritis drug can block a metabolic pathway that occurs in tumors with a common cancer-causing gene mutation, offering a new possible therapy for aggressive cancers with few therapeutic options, according to a study to be published in Cancer Discovery.

3 Mar 2017

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Virtual environment education decreases anxiety before prostate cancer treatment

Researchers study risk of thrombosis and bleeding in urological surgery

Random DNA copying ‘mistakes’ account for most cancer mutations, study finds

Research suggests novel strategy to target genetic anomaly in prostate cancers

New technology may provide non-invasive approach to diagnose and monitor prostate cancer

Vanderbilt study compares side effects, outcomes of prostate cancer treatments with active surveillance

Study sheds light on cellular mechanisms that enable prostate cancer cells to form secondary tumours

Researchers discover new genes that help prevent prostate and other cancers

Compressed course of radiation treatment benefits men with localized prostate cancer, study shows

Study uncovers genetic link to aggressive form of prostate cancer

Dietary anti-cancer compound from broccoli may work by influence on long non-coding RNAs

Endostatin can decrease proliferation of castration-resistant prostate cancer cells

Thyroid cancer patients opting for non-intervention face challenging path, study reveals

Combination therapy that targets immune-busting cells effective in treating advanced prostate cancer

TSRI researchers develop new drug candidates to target prostate and triple negative breast cancers

Fraunhofer researchers develop method that enables focused ultrasound to treat liver tumors

Drug could activate innate anti-tumor immunity to eradicate aggressive prostate cancer in mice

Study offers new insights into biological causes of premature baldness in men

Michigan Medicine opens first clinic in the United States that focuses on prostate cancer risk

Rheumatoid arthritis drug blocks metabolic pathway, reduces breast cancer tumors in mice

What to know about prostate cancer eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in